# Zylox-Tonbridge Recognized as Most Honored Company in Extel 2026 Asia Executive Team Survey

- Link: https://www.thailand-business-news.com/pr-news/zylox-tonbridge-recognized-as-most-honored-company-in-extel-2026-asia-executive-team-survey
- Published: 2026-06-08T17:19:00+07:00
- Author: PR Newswire

|   |

HANGZHOU, China, June 8, 2026 /PRNewswire/ — Zylox-Tonbridge Medical Technology 
Co., Ltd. (HKEX: 2190; "Zylox-Tonbridge" or the "Company"), a Hong Kong-listed medical
technology company focused on neurovascular and peripheral vascular interventional
products and solutions, announced that it has been recognized as a Most Honored 
Company in Extel’s 16th Asia (ex-Japan/ANZ) Executive Team Survey.

[⌊Zylox-Tonbridge Named Most Honored Company in Extel 2026 Asia Executive Team Survey⌉⌊
Zylox-Tonbridge Named Most Honored Company in Extel 2026 Asia Executive Team Survey⌉[
Zylox-Tonbridge
Named Most Honored Company in Extel 2026 Asia Executive Team Survey

The recognition reflects the international investment community’s confidence in 
the Company’s management capabilities, governance standards, disclosure transparency
and investor communication quality, as well as its long-term commitment to sound
governance and steady development.

In this survey, Zylox-Tonbridge was also recognized across multiple categories in
the Healthcare Equipment & Services sector, including Best CEO, Best CFO, Best IR
Program, Best IR Team and Best IR Professional.

Extel, formerly Institutional Investor Research, is an independent research and 
rankings provider widely followed by the global capital markets. Its Asia Executive
Team rankings are based on votes from global investors, portfolio managers and analysts,
with a focus on listed companies’ management teams, investor relations, corporate
governance, ESG performance and boards. According to Extel, the 2026 Asia Executive
Team Survey attracted participation from 5,581 investors, portfolio managers and
analysts from 1,249 voter firms, covering 2,520 companies and 2,728 individuals 
across 23 sectors.

"We are honored to receive recognition from Extel, as well as international investors
and analysts," said Dr. Jonathon Zhao, Chairman and Chief Executive Officer of Zylox-
Tonbridge. "This honor reflects the capital market’s recognition of our corporate
governance standards and management team. It also encourages us to remain focused
on long-term value creation and to continuously enhance our investor relations management.
Looking ahead, we will continue to deepen our innovation-driven and international
development strategies, advance product development, commercialization capabilities
and global market expansion, and bring more high-quality and accessible innovative
solutions to patients worldwide, while continuing to enhance the Company’s long-
term value."

**About Zylox-Tonbridge**

Zylox-Tonbridge Medical Technology Co., Ltd. (HKEX: 2190) is a medical technology
company dedicated to the innovative research and development, manufacturing and 
commercialization of medical devices in the field of vascular intervention. Founded
in 2012 and headquartered in Hangzhou, China, the Company adheres to the brand philosophy
of "Innovation for Quality Life" and is committed to providing high-quality, accessible
medical devices and services.

For more information, please visit [https://www.zyloxtb.com/](https://www.zyloxtb.com/).

 

---

  |  This article was produced by Cision PR Newswire, our trusted news partner. The views expressed and the content presented here are solely those of the author and may not fully reflect the opinions of Thailand Business News. |

---

 
**Read the original article :** [Zylox-Tonbridge Recognized as Most Honored Company in Extel 2026 Asia Executive Team Survey ](http://www.prnasia.com/story/archive/4978048_CN78048_0?rand=184833)